Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 3/20 | 0.43 |
| ▸ | LAP3 | P28838 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9810324 | 1.00 | SLC7A5 (0.50) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| SCHEMBL28610885 | 0.95 | SLC7A5 (0.50) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| SCHEMBL10421343 | 0.91 | SLC7A5 (0.46) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL29401942 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL11140120 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL235250 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL6044006 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL13737576 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL235249 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 | |
| Leu-Leu SCHEMBL18774992 | 0.86 | ALDH1A1 (0.60) | SLC7A5ALDH1A1MAPTMMELAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0264953-B1 | USE OF N,N'-BIS-L-AMINO ACID-L-CYSTIN PEPTIDES IN AMINO ACID PREPARATIONS FOR ORAL AND PARENTERAL ADMINISTRATION | PFRIMMER KABI GMBH & CO. KG (DE) | 1991-05-08 | — | — | EP | claimed |
| EP-2610338-A1 | METHOD FOR PRODUCING SUBSTANCE | Kyowa Hakko Kirin Co., Ltd. (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-20130130317-A1 | METHOD FOR PRODUCING SUBSTANCE | KYOWA HAKKO KIRIN CO., LTD (JP) | 2013-05-23 | — | — | US | disclosed |
| EP-0264953-B1 | USE OF N,N'-BIS-L-AMINO ACID-L-CYSTIN PEPTIDES IN AMINO ACID PREPARATIONS FOR ORAL AND PARENTERAL ADMINISTRATION | PFRIMMER KABI GMBH & CO. KG (DE) | 1991-05-08 | — | — | EP | disclosed |
| US-4968696-A | CHRONIC UREMIA OR HEPATIC CIRRHOSIS | PFRIMMER + CO. PHARMAZEUTISCHE WERKE ERLANGEN GMBH + CO. KG (DE) | 1990-11-06 | — | — | US | disclosed |
| WO-1988003150-A2 | N,N'-BIS-AMINO ACID-L-CYSTINE-PEPTIDE-CONTAINING AMINO ACID PREPARATIONS FOR ORAL AND PARENTERAL ADMINISTRATION | PFRIMMER + CO. PHARMAZEUTISCHE WERKE ERLANGEN GMBH (DE) | 1988-05-05 | — | — | WO | disclosed |